EE525 The Economic Value of Insulin Glargine 300 U/Ml (Gla-300) in People ≥18 Years of Age With Type 2 Diabetes Mellitus: A Value-Based Economic Model From a U.S. Payer Perspective
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.766
https://www.valueinhealthjournal.com/article/S1098-3015(22)02970-9/fulltext
Title :
EE525 The Economic Value of Insulin Glargine 300 U/Ml (Gla-300) in People ≥18 Years of Age With Type 2 Diabetes Mellitus: A Value-Based Economic Model From a U.S. Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02970-9&doi=10.1016/j.jval.2022.09.766
First page :
Section Title :
Open access? :
No
Section Order :
10309